nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—Graves' disease—head and neck cancer	0.831	1	CtDrD
Methimazole—CYP2A6—Fluorouracil—head and neck cancer	0.0432	0.315	CbGbCtD
Methimazole—CYP2D6—Hydroxyurea—head and neck cancer	0.0356	0.259	CbGbCtD
Methimazole—CYP1A2—Fluorouracil—head and neck cancer	0.0165	0.12	CbGbCtD
Methimazole—CYP2C9—Fluorouracil—head and neck cancer	0.0149	0.108	CbGbCtD
Methimazole—CYP2D6—Vinblastine—head and neck cancer	0.0126	0.0917	CbGbCtD
Methimazole—CYP3A4—Vinblastine—head and neck cancer	0.00801	0.0583	CbGbCtD
Methimazole—CYP3A4—Docetaxel—head and neck cancer	0.0066	0.048	CbGbCtD
Methimazole—Drug fever—Docetaxel—head and neck cancer	0.00084	0.0731	CcSEcCtD
Methimazole—Neuritis—Vinblastine—head and neck cancer	0.000793	0.069	CcSEcCtD
Methimazole—Neuritis—Docetaxel—head and neck cancer	0.000376	0.0327	CcSEcCtD
Methimazole—Ageusia—Docetaxel—head and neck cancer	0.000346	0.0301	CcSEcCtD
Methimazole—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000325	0.0283	CcSEcCtD
Methimazole—Agranulocytosis—Vinblastine—head and neck cancer	0.000309	0.0269	CcSEcCtD
Methimazole—Drowsiness—Hydroxyurea—head and neck cancer	0.000302	0.0263	CcSEcCtD
Methimazole—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000296	0.0258	CcSEcCtD
Methimazole—Alopecia—Vinblastine—head and neck cancer	0.000263	0.0229	CcSEcCtD
Methimazole—Alopecia—Hydroxyurea—head and neck cancer	0.00024	0.0209	CcSEcCtD
Methimazole—Vertigo—Vinblastine—head and neck cancer	0.000233	0.0202	CcSEcCtD
Methimazole—Leukopenia—Vinblastine—head and neck cancer	0.000232	0.0202	CcSEcCtD
Methimazole—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000213	0.0185	CcSEcCtD
Methimazole—Leukopenia—Hydroxyurea—head and neck cancer	0.000211	0.0184	CcSEcCtD
Methimazole—Thrombocytopenia—Vinblastine—head and neck cancer	0.000207	0.018	CcSEcCtD
Methimazole—Agranulocytosis—Fluorouracil—head and neck cancer	0.000203	0.0177	CcSEcCtD
Methimazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—head and neck cancer	0.000194	0.0096	CbGpPWpGaD
Methimazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000194	0.00959	CbGpPWpGaD
Methimazole—Oedema—Hydroxyurea—head and neck cancer	0.000193	0.0168	CcSEcCtD
Methimazole—Paraesthesia—Vinblastine—head and neck cancer	0.00019	0.0165	CcSEcCtD
Methimazole—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000189	0.00937	CbGpPWpGaD
Methimazole—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000189	0.0164	CcSEcCtD
Methimazole—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000183	0.00905	CbGpPWpGaD
Methimazole—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000183	0.00905	CbGpPWpGaD
Methimazole—TPO—Metabolism—UROD—head and neck cancer	0.000177	0.00875	CbGpPWpGaD
Methimazole—Alopecia—Fluorouracil—head and neck cancer	0.000172	0.015	CcSEcCtD
Methimazole—Somnolence—Hydroxyurea—head and neck cancer	0.000171	0.0149	CcSEcCtD
Methimazole—Dyspepsia—Hydroxyurea—head and neck cancer	0.00017	0.0148	CcSEcCtD
Methimazole—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.000166	0.00823	CbGpPWpGaD
Methimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000165	0.00819	CbGpPWpGaD
Methimazole—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00016	0.00791	CbGpPWpGaD
Methimazole—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000155	0.00767	CbGpPWpGaD
Methimazole—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000154	0.0134	CcSEcCtD
Methimazole—Jaundice—Docetaxel—head and neck cancer	0.000153	0.0133	CcSEcCtD
Methimazole—CYP2D6—Xenobiotics—CYP1A1—head and neck cancer	0.000153	0.00757	CbGpPWpGaD
Methimazole—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000153	0.00756	CbGpPWpGaD
Methimazole—Body temperature increased—Hydroxyurea—head and neck cancer	0.000152	0.0133	CcSEcCtD
Methimazole—Leukopenia—Fluorouracil—head and neck cancer	0.000152	0.0132	CcSEcCtD
Methimazole—CYP2C9—Xenobiotics—CYP1A1—head and neck cancer	0.000152	0.0075	CbGpPWpGaD
Methimazole—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000149	0.00736	CbGpPWpGaD
Methimazole—CYP2D6—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000147	0.00728	CbGpPWpGaD
Methimazole—Agranulocytosis—Docetaxel—head and neck cancer	0.000146	0.0127	CcSEcCtD
Methimazole—CYP2C9—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000146	0.00722	CbGpPWpGaD
Methimazole—Myalgia—Fluorouracil—head and neck cancer	0.000145	0.0126	CcSEcCtD
Methimazole—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000141	0.00698	CbGpPWpGaD
Methimazole—Hepatitis—Docetaxel—head and neck cancer	0.000141	0.0123	CcSEcCtD
Methimazole—Oedema—Fluorouracil—head and neck cancer	0.000139	0.0121	CcSEcCtD
Methimazole—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000136	0.0118	CcSEcCtD
Methimazole—Vomiting—Vinblastine—head and neck cancer	0.000134	0.0117	CcSEcCtD
Methimazole—Headache—Vinblastine—head and neck cancer	0.000132	0.0115	CcSEcCtD
Methimazole—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.000129	0.00641	CbGpPWpGaD
Methimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000128	0.00632	CbGpPWpGaD
Methimazole—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000126	0.011	CcSEcCtD
Methimazole—Nausea—Vinblastine—head and neck cancer	0.000125	0.0109	CcSEcCtD
Methimazole—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000125	0.00617	CbGpPWpGaD
Methimazole—Paraesthesia—Fluorouracil—head and neck cancer	0.000125	0.0108	CcSEcCtD
Methimazole—Alopecia—Docetaxel—head and neck cancer	0.000124	0.0108	CcSEcCtD
Methimazole—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000123	0.00611	CbGpPWpGaD
Methimazole—Somnolence—Fluorouracil—head and neck cancer	0.000123	0.0107	CcSEcCtD
Methimazole—Vomiting—Hydroxyurea—head and neck cancer	0.000122	0.0107	CcSEcCtD
Methimazole—Dyspepsia—Fluorouracil—head and neck cancer	0.000122	0.0106	CcSEcCtD
Methimazole—Rash—Hydroxyurea—head and neck cancer	0.000121	0.0106	CcSEcCtD
Methimazole—Dermatitis—Hydroxyurea—head and neck cancer	0.000121	0.0106	CcSEcCtD
Methimazole—Headache—Hydroxyurea—head and neck cancer	0.000121	0.0105	CcSEcCtD
Methimazole—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000119	0.00592	CbGpPWpGaD
Methimazole—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000115	0.00568	CbGpPWpGaD
Methimazole—Nausea—Hydroxyurea—head and neck cancer	0.000114	0.00996	CcSEcCtD
Methimazole—CYP2D6—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000114	0.00562	CbGpPWpGaD
Methimazole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000113	0.00561	CbGpPWpGaD
Methimazole—CYP2A6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000112	0.00553	CbGpPWpGaD
Methimazole—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000111	0.00548	CbGpPWpGaD
Methimazole—Urticaria—Fluorouracil—head and neck cancer	0.00011	0.00959	CcSEcCtD
Methimazole—Leukopenia—Docetaxel—head and neck cancer	0.00011	0.00955	CcSEcCtD
Methimazole—Body temperature increased—Fluorouracil—head and neck cancer	0.00011	0.00954	CcSEcCtD
Methimazole—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000109	0.00538	CbGpPWpGaD
Methimazole—Myalgia—Docetaxel—head and neck cancer	0.000104	0.00909	CcSEcCtD
Methimazole—Arthralgia—Docetaxel—head and neck cancer	0.000104	0.00909	CcSEcCtD
Methimazole—CYP2A6—Biological oxidations—NAT2—head and neck cancer	0.000104	0.00516	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—TGFA—head and neck cancer	0.000101	0.005	CbGpPWpGaD
Methimazole—Oedema—Docetaxel—head and neck cancer	0.0001	0.00871	CcSEcCtD
Methimazole—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	9.99e-05	0.00495	CbGpPWpGaD
Methimazole—Pruritus—Fluorouracil—head and neck cancer	9.81e-05	0.00854	CcSEcCtD
Methimazole—Thrombocytopenia—Docetaxel—head and neck cancer	9.8e-05	0.00853	CcSEcCtD
Methimazole—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	9.62e-05	0.00476	CbGpPWpGaD
Methimazole—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	9.61e-05	0.00476	CbGpPWpGaD
Methimazole—CYP2A6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.18e-05	0.00454	CbGpPWpGaD
Methimazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.13e-05	0.00452	CbGpPWpGaD
Methimazole—Musculoskeletal discomfort—Docetaxel—head and neck cancer	9.12e-05	0.00794	CcSEcCtD
Methimazole—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.01e-05	0.00446	CbGpPWpGaD
Methimazole—Paraesthesia—Docetaxel—head and neck cancer	8.99e-05	0.00782	CcSEcCtD
Methimazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	8.94e-05	0.00443	CbGpPWpGaD
Methimazole—Somnolence—Docetaxel—head and neck cancer	8.9e-05	0.00774	CcSEcCtD
Methimazole—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	8.83e-05	0.00437	CbGpPWpGaD
Methimazole—Vomiting—Fluorouracil—head and neck cancer	8.82e-05	0.00767	CcSEcCtD
Methimazole—Dyspepsia—Docetaxel—head and neck cancer	8.81e-05	0.00767	CcSEcCtD
Methimazole—Rash—Fluorouracil—head and neck cancer	8.74e-05	0.00761	CcSEcCtD
Methimazole—Dermatitis—Fluorouracil—head and neck cancer	8.73e-05	0.0076	CcSEcCtD
Methimazole—Headache—Fluorouracil—head and neck cancer	8.69e-05	0.00756	CcSEcCtD
Methimazole—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	8.48e-05	0.0042	CbGpPWpGaD
Methimazole—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	8.45e-05	0.00419	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—NAT2—head and neck cancer	8.4e-05	0.00416	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—NAT2—head and neck cancer	8.28e-05	0.0041	CbGpPWpGaD
Methimazole—Nausea—Fluorouracil—head and neck cancer	8.24e-05	0.00717	CcSEcCtD
Methimazole—CYP2E1—Biological oxidations—NAT2—head and neck cancer	8.23e-05	0.00407	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	8.11e-05	0.00402	CbGpPWpGaD
Methimazole—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	8.07e-05	0.00399	CbGpPWpGaD
Methimazole—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	7.98e-05	0.00395	CbGpPWpGaD
Methimazole—Body temperature increased—Docetaxel—head and neck cancer	7.91e-05	0.00689	CcSEcCtD
Methimazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.4e-05	0.00367	CbGpPWpGaD
Methimazole—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	7.35e-05	0.00364	CbGpPWpGaD
Methimazole—TPO—Metabolism—NAT2—head and neck cancer	7.34e-05	0.00363	CbGpPWpGaD
Methimazole—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	7.28e-05	0.00361	CbGpPWpGaD
Methimazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.25e-05	0.00359	CbGpPWpGaD
Methimazole—Pruritus—Docetaxel—head and neck cancer	7.08e-05	0.00616	CcSEcCtD
Methimazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	6.9e-05	0.00342	CbGpPWpGaD
Methimazole—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	6.81e-05	0.00337	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	6.65e-05	0.00329	CbGpPWpGaD
Methimazole—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	6.65e-05	0.00329	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	6.65e-05	0.00329	CbGpPWpGaD
Methimazole—CYP2A6—Fluoropyrimidine Activity—TP53—head and neck cancer	6.46e-05	0.0032	CbGpPWpGaD
Methimazole—TPO—Metabolism—DPYD—head and neck cancer	6.44e-05	0.00319	CbGpPWpGaD
Methimazole—Vomiting—Docetaxel—head and neck cancer	6.36e-05	0.00554	CcSEcCtD
Methimazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	6.35e-05	0.00314	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—NAT2—head and neck cancer	6.35e-05	0.00314	CbGpPWpGaD
Methimazole—Rash—Docetaxel—head and neck cancer	6.31e-05	0.00549	CcSEcCtD
Methimazole—Dermatitis—Docetaxel—head and neck cancer	6.3e-05	0.00549	CcSEcCtD
Methimazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	6.29e-05	0.00312	CbGpPWpGaD
Methimazole—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	6.28e-05	0.00311	CbGpPWpGaD
Methimazole—Headache—Docetaxel—head and neck cancer	6.27e-05	0.00546	CcSEcCtD
Methimazole—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	6.26e-05	0.0031	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	6.26e-05	0.0031	CbGpPWpGaD
Methimazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	6.22e-05	0.00308	CbGpPWpGaD
Methimazole—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	6.21e-05	0.00308	CbGpPWpGaD
Methimazole—TPO—Metabolism—YAP1—head and neck cancer	6.11e-05	0.00302	CbGpPWpGaD
Methimazole—Nausea—Docetaxel—head and neck cancer	5.94e-05	0.00517	CcSEcCtD
Methimazole—CYP2A6—NRF2 pathway—GSTM1—head and neck cancer	5.86e-05	0.0029	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—NAT2—head and neck cancer	5.84e-05	0.00289	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—NAT2—head and neck cancer	5.79e-05	0.00287	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	5.76e-05	0.00285	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	5.71e-05	0.00283	CbGpPWpGaD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.59e-05	0.00277	CbGpPWpGaD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.38e-05	0.00266	CbGpPWpGaD
Methimazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.31e-05	0.00263	CbGpPWpGaD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.15e-05	0.00255	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—GSTM1—head and neck cancer	5.14e-05	0.00255	CbGpPWpGaD
Methimazole—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	5.13e-05	0.00254	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.1e-05	0.00253	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—NAT2—head and neck cancer	4.95e-05	0.00245	CbGpPWpGaD
Methimazole—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	4.92e-05	0.00244	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	4.88e-05	0.00242	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	4.87e-05	0.00241	CbGpPWpGaD
Methimazole—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.75e-05	0.00235	CbGpPWpGaD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.36e-05	0.00216	CbGpPWpGaD
Methimazole—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	4.33e-05	0.00214	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—UROD—head and neck cancer	4.29e-05	0.00212	CbGpPWpGaD
Methimazole—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	4.18e-05	0.00207	CbGpPWpGaD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.15e-05	0.00206	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—GSTM1—head and neck cancer	4.15e-05	0.00205	CbGpPWpGaD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.1e-05	0.00203	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—GSTM1—head and neck cancer	4.09e-05	0.00203	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	4.06e-05	0.00201	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	4.01e-05	0.00198	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	3.96e-05	0.00196	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—CYP1A1—head and neck cancer	3.93e-05	0.00195	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP1A1—head and neck cancer	3.88e-05	0.00192	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	3.85e-05	0.00191	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—NAT2—head and neck cancer	3.82e-05	0.00189	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	3.8e-05	0.00188	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	3.76e-05	0.00186	CbGpPWpGaD
Methimazole—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	3.7e-05	0.00183	CbGpPWpGaD
Methimazole—TPO—Metabolism—TYMS—head and neck cancer	3.67e-05	0.00182	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	3.67e-05	0.00182	CbGpPWpGaD
Methimazole—TPO—Metabolism—GSTM1—head and neck cancer	3.62e-05	0.00179	CbGpPWpGaD
Methimazole—TPO—Metabolism—GPX1—head and neck cancer	3.47e-05	0.00172	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—UROD—head and neck cancer	3.46e-05	0.00171	CbGpPWpGaD
Methimazole—TPO—Metabolism—CYP1A1—head and neck cancer	3.44e-05	0.0017	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—UROD—head and neck cancer	3.39e-05	0.00168	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.36e-05	0.00167	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	3.13e-05	0.00155	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	3.12e-05	0.00154	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	3.09e-05	0.00153	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	2.97e-05	0.00147	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	2.93e-05	0.00145	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	2.88e-05	0.00143	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	2.86e-05	0.00142	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	2.84e-05	0.00141	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	2.82e-05	0.0014	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	2.8e-05	0.00139	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	2.8e-05	0.00139	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	2.8e-05	0.00139	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	2.73e-05	0.00135	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	2.71e-05	0.00134	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	2.7e-05	0.00133	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	2.67e-05	0.00132	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—UROD—head and neck cancer	2.61e-05	0.00129	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	2.44e-05	0.00121	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	2.41e-05	0.00119	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—UROD—head and neck cancer	2.4e-05	0.00119	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—UROD—head and neck cancer	2.38e-05	0.00118	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	2.32e-05	0.00115	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	2.28e-05	0.00113	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	2.25e-05	0.00111	CbGpPWpGaD
Methimazole—TPO—Metabolism—PTGS2—head and neck cancer	2.04e-05	0.00101	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—UROD—head and neck cancer	2.04e-05	0.00101	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.03e-05	0.001	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.89e-05	0.000934	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.86e-05	0.000921	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.85e-05	0.000916	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.79e-05	0.000885	CbGpPWpGaD
Methimazole—TPO—Metabolism—PTEN—head and neck cancer	1.78e-05	0.000882	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NAT2—head and neck cancer	1.78e-05	0.000882	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.76e-05	0.000873	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.58e-05	0.000783	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—UROD—head and neck cancer	1.57e-05	0.000778	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—DPYD—head and neck cancer	1.56e-05	0.000773	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—YAP1—head and neck cancer	1.48e-05	0.000734	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NAT2—head and neck cancer	1.44e-05	0.000711	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NAT2—head and neck cancer	1.41e-05	0.000697	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—DPYD—head and neck cancer	1.26e-05	0.000624	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CA—head and neck cancer	1.26e-05	0.000623	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—DPYD—head and neck cancer	1.23e-05	0.000611	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—YAP1—head and neck cancer	1.2e-05	0.000592	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—YAP1—head and neck cancer	1.17e-05	0.00058	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.15e-05	0.000571	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.14e-05	0.000565	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NAT2—head and neck cancer	1.09e-05	0.000538	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.05e-05	0.000521	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.04e-05	0.000515	CbGpPWpGaD
Methimazole—TPO—Metabolism—AKT1—head and neck cancer	1.03e-05	0.000509	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NAT2—head and neck cancer	9.98e-06	0.000494	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NAT2—head and neck cancer	9.9e-06	0.00049	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—DPYD—head and neck cancer	9.52e-06	0.000471	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—YAP1—head and neck cancer	9.03e-06	0.000447	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.98e-06	0.000445	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—TYMS—head and neck cancer	8.9e-06	0.00044	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.89e-06	0.00044	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GSTM1—head and neck cancer	8.79e-06	0.000435	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—DPYD—head and neck cancer	8.75e-06	0.000434	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—DPYD—head and neck cancer	8.68e-06	0.00043	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NAT2—head and neck cancer	8.46e-06	0.000419	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GPX1—head and neck cancer	8.42e-06	0.000417	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP1A1—head and neck cancer	8.34e-06	0.000413	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—YAP1—head and neck cancer	8.31e-06	0.000411	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—YAP1—head and neck cancer	8.24e-06	0.000408	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—DPYD—head and neck cancer	7.42e-06	0.000367	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—TYMS—head and neck cancer	7.18e-06	0.000355	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GSTM1—head and neck cancer	7.09e-06	0.000351	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—YAP1—head and neck cancer	7.04e-06	0.000348	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—TYMS—head and neck cancer	7.03e-06	0.000348	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GSTM1—head and neck cancer	6.95e-06	0.000344	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GPX1—head and neck cancer	6.79e-06	0.000336	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.79e-06	0.000336	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP1A1—head and neck cancer	6.73e-06	0.000333	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GPX1—head and neck cancer	6.65e-06	0.00033	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP1A1—head and neck cancer	6.59e-06	0.000326	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NAT2—head and neck cancer	6.53e-06	0.000323	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.19e-06	0.000306	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.92e-06	0.000293	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—DPYD—head and neck cancer	5.72e-06	0.000283	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—YAP1—head and neck cancer	5.43e-06	0.000269	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—TYMS—head and neck cancer	5.42e-06	0.000269	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.4e-06	0.000267	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GSTM1—head and neck cancer	5.36e-06	0.000265	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.29e-06	0.000262	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GPX1—head and neck cancer	5.13e-06	0.000254	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP1A1—head and neck cancer	5.08e-06	0.000252	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—TYMS—head and neck cancer	4.99e-06	0.000247	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTGS2—head and neck cancer	4.96e-06	0.000245	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—TYMS—head and neck cancer	4.95e-06	0.000245	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GSTM1—head and neck cancer	4.93e-06	0.000244	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GSTM1—head and neck cancer	4.89e-06	0.000242	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GPX1—head and neck cancer	4.72e-06	0.000234	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GPX1—head and neck cancer	4.68e-06	0.000232	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP1A1—head and neck cancer	4.67e-06	0.000231	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP1A1—head and neck cancer	4.63e-06	0.000229	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.61e-06	0.000228	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—head and neck cancer	4.32e-06	0.000214	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—TYMS—head and neck cancer	4.23e-06	0.000209	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GSTM1—head and neck cancer	4.18e-06	0.000207	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.18e-06	0.000207	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GPX1—head and neck cancer	4e-06	0.000198	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTGS2—head and neck cancer	4e-06	0.000198	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP1A1—head and neck cancer	3.96e-06	0.000196	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTGS2—head and neck cancer	3.92e-06	0.000194	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.81e-06	0.000189	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—head and neck cancer	3.49e-06	0.000173	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—head and neck cancer	3.42e-06	0.000169	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—TYMS—head and neck cancer	3.26e-06	0.000162	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.25e-06	0.000161	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GSTM1—head and neck cancer	3.22e-06	0.00016	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPX1—head and neck cancer	3.09e-06	0.000153	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.06e-06	0.000151	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—head and neck cancer	3.05e-06	0.000151	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTGS2—head and neck cancer	3.02e-06	0.00015	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.78e-06	0.000138	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.76e-06	0.000136	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—head and neck cancer	2.64e-06	0.000131	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—head and neck cancer	2.49e-06	0.000123	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—head and neck cancer	2.46e-06	0.000122	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—head and neck cancer	2.42e-06	0.00012	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—head and neck cancer	2.41e-06	0.000119	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—head and neck cancer	2.4e-06	0.000119	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.35e-06	0.000117	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—head and neck cancer	2.05e-06	0.000102	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—head and neck cancer	2.01e-06	9.95e-05	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—head and neck cancer	1.97e-06	9.75e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.86e-06	9.21e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.82e-06	9e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.71e-06	8.47e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.7e-06	8.4e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—head and neck cancer	1.58e-06	7.85e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—head and neck cancer	1.52e-06	7.52e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.45e-06	7.17e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—head and neck cancer	1.4e-06	6.92e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—head and neck cancer	1.39e-06	6.86e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—head and neck cancer	1.18e-06	5.86e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.12e-06	5.54e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—head and neck cancer	9.13e-07	4.52e-05	CbGpPWpGaD
